LEXARIA BIOSCIENCE CORP. Adjustment of Warrants Granted for Services
LEXARIA BIOSCIENCE CORP. (LEXX) reported Adjustment of Warrants Granted for Services of $0 for the 12-month period ending 2022-08-31, per its 10-K filed 2022-11-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for the quarter ending 2021-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for the quarter ending 2020-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for the quarter ending 2020-05-31 was $98.08K.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for the quarter ending 2020-02-29 was $0.00.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for fiscal 2021 was $785.89K, a 365.49% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for fiscal 2020 was $168.83K, a 219.66% increase from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. adjustment of warrants granted for services for fiscal 2019 was $52.82K, a 95.03% decline from fiscal 2018.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|
| 2022-08-31 | $0.00 10-K · filed 2022-11-28 | |||
| 2021-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $785.89K 10-K · filed 2022-11-28 | ||
| 2021-05-31 | $785.89K 10-Q · filed 2021-07-15 | |||
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $98.08K derived: sum of 2 quarters · filed 2021-11-29 | $98.08K derived: sum of 3 quarters · filed 2021-11-29 | $168.83K 10-K · filed 2021-11-29 |
| 2020-05-31 | $98.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $98.08K derived: sum of 2 quarters · filed 2021-07-15 | $168.83K 10-Q · filed 2021-07-15 | $168.83K derived: sum of 4 quarters · filed 2021-07-15 |
| 2020-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $70.75K 10-Q · filed 2021-04-14 | $70.75K derived: sum of 3 quarters · filed 2021-04-14 | |
| 2019-11-30 | $70.75K 10-Q · filed 2021-01-14 | $70.75K derived: sum of 2 quarters · filed 2021-01-14 | ||
| 2019-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $52.82K 10-K · filed 2020-10-15 | ||
| 2019-05-31 | $52.82K 10-Q · filed 2020-06-29 | |||
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $1.06M 10-K · filed 2019-11-14 | ||
| 2018-05-31 | $1.06M 10-Q · filed 2019-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |